discovery - understanding - development - exploitation
As part of the Applied Exomics commitment to supporting the development of biologics a new, free developability platform is
now available to all.
Let's take the first step towards successful development together!
Incorporating in silico methodologies into your discovery pipeline can bring significant cost-benefits at every stage; from target discovery, characterisation, validation, through product design and development, and on towards translation to the clinic. Improve your chance of success and base decisions on the best available data.
Reaching the point of having a lead biologic is a significant challenge. Moving towards scale-up production an clinical application even more so. With increasing recognition of the value of developability assessment across the industry, we can work together to assess your developability risks and optimise for success.